Prafull S. Gandhi
Prafull S. Gandhi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Henrik Østergaard
¶Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark
2 shared publications- Michael Toft Overgaard
Department of Chemistry and Bioscience, Aalborg University
2 shared publications Ole H. Olsen
¶Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology, University of Copenhagen, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark
2 shared publicationsAnders B. Sorensen
From Global Research, Novo Nordisk A/S, 2760 Måløv, Denmark, Department of Chemistry and Bioscience, Aalborg University, 9220 Aalborg, Denmark, and
1 shared publication- Anders Bundgaard Sørensen
Evaxion Biotech A/S, Hoersholm, Denmark
1 shared publication Anette A. Pedersen
From Global Research, Novo Nordisk A/S, 2760 Måløv, Denmark
1 shared publication
Latest Publications
- Open Access
- 11 February 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (4) , 1181
Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative
Somapacitan is a long-acting, once-weekly, albumin-binding growth hormone (GH) derivative. The reversible albumin-binding properties leads to prolonged circulation half-life. Here, we investigated and compared somapacitan with human GH on downstream receptor signaling in primary hepatocytes and hepatocellular models and using isothermal titration calorimetry to characterize receptor binding of somapacitan in the presence or absence of human serum albumin (HSA). With non-invasive fluorescence imaging we quantitatively visualize and compare the temporal distribution and examine the tissue-specific growth hormone receptor (GHR) activation at distribution sites. We found that signaling kinetics were slightly more rapid and intense for GH compared with somapacitan. Receptor binding isotherms were characterized by a high and a low affinity interaction site with or without HSA. Using in vivo optical imaging we found prolonged systemically biodistribution of somapacitan compared with GH, which correlated with plasma pharmacokinetics. Ex vivo mouse organ analysis revealed that the temporal fluorescent intensity in livers dosed with somapacitan was significantly increased compared with GH-dosed livers and correlated with the degree of downstream GHR activation. Finally, we show that fluorescent-labeled analogs distributed to the hypertrophic zone in the epiphysis of proximal tibia of hypophysectomized rats and that somapacitan and GH activate the GHR signaling in epiphyseal tissues.
- 11 February 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (4) , 1181
Open AccessTissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative
Somapacitan is a long-acting, once-weekly, albumin-binding growth hormone (GH) derivative. The reversible albumin-binding properties leads to prolonged circulation half-life. Here, we investigated and compared somapacitan with human GH on downstream receptor signaling in primary hepatocytes and hepatocellular models and using isothermal titration calorimetry to characterize receptor binding of somapacitan in the presence or absence of human serum albumin (HSA). With non-invasive fluorescence imaging we quantitatively visualize and compare the temporal distribution and examine the tissue-specific growth hormone receptor (GHR) activation at distribution sites. We found that signaling kinetics were slightly more rapid and intense for GH compared with somapacitan. Receptor binding isotherms were characterized by a high and a low affinity interaction site with or without HSA. Using in vivo optical imaging we found prolonged systemically biodistribution of somapacitan compared with GH, which correlated with plasma pharmacokinetics. Ex vivo mouse organ analysis revealed that the temporal fluorescent intensity in livers dosed with somapacitan was significantly increased compared with GH-dosed livers and correlated with the degree of downstream GHR activation. Finally, we show that fluorescent-labeled analogs distributed to the hypertrophic zone in the epiphysis of proximal tibia of hypophysectomized rats and that somapacitan and GH activate the GHR signaling in epiphyseal tissues.
- Open Access
- 1 January 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (2) , 517-528
Beating tissue factor at its own game: Design and properties of a soluble tissue factor–independent coagulation factor VIIa
- 1 January 2020
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (2) , 517-528
Open AccessBeating tissue factor at its own game: Design and properties of a soluble tissue factor–independent coagulation factor VIIa
- Open Access
- 1 February 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (9) , 4671-4683
Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity
- 1 February 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (9) , 4671-4683
Open AccessMolecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity